Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
837 studies found for:    "Crohn disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Crohn disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed STA-5326 in Crohn's Disease Patients
Condition: Crohn's Disease
Intervention: Drug: STA-5326
2 Enrolling by invitation Clinical Course of Korean Crohn's Disease Cohort
Condition: Crohn's Disease
Intervention: Other: Observation study
3 Completed EPANOVA in Crohn's Disease, Study 1
Condition: Crohn's Disease
Intervention: Drug: Epanova
4 Unknown  Evaluation of PET CT in the Management of Patients With Crohn's Disease.
Condition: Crohn's Disease
Intervention: Radiation: FDG PET CT
5 Unknown  Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study
Condition: Crohn's Disease
Intervention: Drug: Pravastatin
6 Active, not recruiting Special Investigation on Long-term Treatment in Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention:
7 Completed Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn's Disease Patients
Condition: Crohn Disease
Intervention:
8 Completed
Has Results
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)
Condition: Crohn's Disease
Intervention:
9 Terminated Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine)
10 Terminated Imuran Dosing in Crohn's Disease Study
Condition: Crohn's Disease
Intervention: Drug: IMURAN (azathioprine)
11 Recruiting A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: E6011 2 mg/kg;   Drug: E6011 5 mg/kg;   Drug: E6011 10 mg/kg;   Drug: E6011 15 mg/kg
12 Completed
Has Results
Study for the Treatment of Crohn's Disease With Adacolumn
Condition: Crohn's Disease
Interventions: Device: Adacolumn;   Device: Sham
13 Active, not recruiting Extension Study of MT-1303 in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: MT-1303
14 Active, not recruiting Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity
Condition: Crohn's Disease
Interventions: Procedure: Fecal calprotectin;   Procedure: Urinary PGE-M Level
15 Recruiting Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease
Condition: Crohn's Disease
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Moderate Oligosaccharide Group;   Dietary Supplement: High Oligosaccharide Group
16 Completed
Has Results
Safety and Maintenance Study of Entocort for Children With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Entocort
17 Completed An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Infliximab 5 mg/kg;   Drug: Infliximab 10 mg/kg;   Drug: Infliximab 20 mg/kg;   Drug: Placebo
18 Terminated Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Nitazoxanide;   Other: Placebo
19 Completed Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: MT-1303
20 Completed A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: infliximab or placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.